Pfizer (PFE) reported Q1 FY 2017 earnings of $0.69 per share (versus $0.67 in Q1 FY 2016), beating analysts' consensus estimate of $0.67.
The company's quarterly revenues amounted to $12.779 bln (-1.7% y/y), missing analysts' consensus estimate of $13.089 bln.
PFE fell to $33.50 (-0.83%) in pre-market trading.